{"id":"W2973123957","doi":"10.1097/coc.0000000000000599","title":"Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Quest University Canada","funders":"National Cancer Institute","keywords":"Medicine; Nelfinavir; Gemcitabine; Chemoimmunotherapy; Pancreatic cancer; Internal medicine; FOLFIRINOX; Adenocarcinoma; Oncology; Surgery; Gastroenterology; Cancer; Irinotecan; Immunotherapy; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003243167,0.0002806552,0.004053267,0.0001958699,0.00006827601,0.00000870906,0.0002900542,0.0002752779,0.0001733834],"category_scores_gemma":[0.002188683,0.0002064372,0.0006393256,0.0002548369,0.001172629,0.0001012774,0.0000321738,0.0007222294,0.000003092054],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002138622,"about_ca_system_score_gemma":0.003623034,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003714415,"about_ca_topic_score_gemma":0.000002236227,"domain_scores_codex":[0.9953345,0.0007124862,0.002592362,0.0003737447,0.0004708552,0.0005160289],"domain_scores_gemma":[0.989491,0.006297188,0.002668316,0.000442823,0.0005136894,0.0005869265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5658086,0.009885711,0.08741748,0.0000897145,0.001578177,0.0001104204,0.0002111329,0.00000196908,0.0154821,0.00003054624,0.001341609,0.3180425],"study_design_scores_gemma":[0.466094,0.4941013,0.0147858,0.0002128063,0.0008694931,0.0002270898,0.0002606768,0.001501746,0.0003617761,0.00005893148,0.02131843,0.0002080311],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879788,0.001889809,0.002273143,0.005345543,0.0004736527,0.00175504,0.00001571731,0.00001148818,0.0002568324],"genre_scores_gemma":[0.9789956,0.001823481,0.01549652,0.00274709,0.0003405442,0.00004792072,0.00001067042,0.00005141436,0.0004868047],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4842155,"threshold_uncertainty_score":0.8418265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04319597588248913,"score_gpt":0.4525099512132602,"score_spread":0.409313975330771,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}